Literature DB >> 11890882

Reflex sympathetic dystrophy.

Robert J Schwartzman1, Anca Popescu.   

Abstract

Reflex sympathetic dystrophy (RSD) is composed of five major features: pain, swelling, autonomic dysregulation, movement disorders, and atrophy and dystrophy. RSD is caused by an injury to a specific nerve or the C- and A-delta fibers that innervate the involved tissue. It is a progressive illness that spreads with time and may encompass the entire body. There is no psychological disposition to the problem, but all patients are severely depressed because of the constant pain, lack of sleep, and complete disruption of their lifestyle. The continuing pain is usually secondary to the process of central sensitization. The autonomic dysregulation has a major central nervous system component. Atrophy and dystrophy are partly due to loss of nutritive blood supply to the affected tissues. The movement disorder is partly due to deficiency of GABAergic mechanisms; the tremor is an exaggeration of the normal physiologic tremor. Treatment consists of decreasing the afferent pain, maintaining barrage from the underlying defect, and blocking the sympathetic component of the process. New developments include the use of neurotrophic factors to reverse the phenotypic changes that occur in the dorsal horn and the use of pharmacologic agents to block the activity-dependent NMDA channels that appear to be instrumental in maintaining central sensitization.

Entities:  

Mesh:

Year:  2002        PMID: 11890882     DOI: 10.1007/s11926-002-0012-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  22 in total

Review 1.  Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain.

Authors:  R R Ji; C J Woolf
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

2.  Explaining reflex sympathetic dystrophy.

Authors:  R J Schwartzman
Journal:  Arch Neurol       Date:  1999-05

3.  Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1.

Authors:  C Sommer; C Schmidt; A George
Journal:  Exp Neurol       Date:  1998-05       Impact factor: 5.330

Review 4.  Postinjury neuropathic pain syndromes.

Authors:  R J Schwartzman; J Maleki
Journal:  Med Clin North Am       Date:  1999-05       Impact factor: 5.456

Review 5.  Neuroimmune alterations in the complex regional pain syndrome.

Authors:  F J Huygen; A G de Bruijn; J Klein; F J Zijlstra
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

Review 6.  The molecular dynamics of pain control.

Authors:  S P Hunt; P W Mantyh
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

7.  An unusual case of chronic neuropathic pain responds to an optimum frequency of intravenous ketamine infusions.

Authors:  A C Mitchell
Journal:  J Pain Symptom Manage       Date:  2001-05       Impact factor: 3.612

8.  Acute effects of substance P and calcitonin gene-related peptide in human skin--a microdialysis study.

Authors:  C Weidner; M Klede; R Rukwied; G Lischetzki; U Neisius; P S Skov; L J Petersen; M Schmelz
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

9.  Metabolic changes in reflex sympathetic dystrophy: a 31P NMR spectroscopy study.

Authors:  A Heerschap; J A den Hollander; H Reynen; R J Goris
Journal:  Muscle Nerve       Date:  1993-04       Impact factor: 3.217

10.  The spinal component to skin blood flow abnormalities in reflex sympathetic dystrophy.

Authors:  H A Kurvers; M J Jacobs; R J Beuk; F A van den Wildenberg; P J Kitslaar; D W Slaaf; R S Reneman
Journal:  Arch Neurol       Date:  1996-01
View more
  6 in total

1.  Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.

Authors:  Michael E Goldberg; Marc C Torjman; Robert J Schwartzman; Donald E Mager; Irving W Wainer
Journal:  Pain Physician       Date:  2010 Jul-Aug       Impact factor: 4.965

Review 2.  Influence of sympathetic nervous system on sensorimotor function: whiplash associated disorders (WAD) as a model.

Authors:  Magda Passatore; Silvestro Roatta
Journal:  Eur J Appl Physiol       Date:  2006-10-12       Impact factor: 3.078

3.  Computer-assisted skin videothermography is a highly sensitive quality tool in the diagnosis and monitoring of complex regional pain syndrome type I.

Authors:  Frank J P M Huygen; Sjoerd Niehof; Jan Klein; Freek J Zijlstra
Journal:  Eur J Appl Physiol       Date:  2004-01-21       Impact factor: 3.078

4.  Pain acceptance-based coping in complex regional pain syndrome Type I: daily relations with pain intensity, activity, and mood.

Authors:  Sungkun Cho; Lance M McCracken; Elaine M Heiby; Dong-Eon Moon; Jang-Han Lee
Journal:  J Behav Med       Date:  2012-08-02

5.  Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1.

Authors:  J George Groeneweg; Frank J P M Huygen; Claudia Heijmans-Antonissen; Sjoerd Niehof; Freek J Zijlstra
Journal:  BMC Musculoskelet Disord       Date:  2006-11-30       Impact factor: 2.362

6.  Six years follow-up of the levels of TNF-alpha and IL-6 in patients with complex regional pain syndrome type 1.

Authors:  Feikje Wesseldijk; Frank J P M Huygen; Claudia Heijmans-Antonissen; Sjoerd P Niehof; Freek J Zijlstra
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.